, Tracking Stock Market Picks
Enter Symbol:
St. Jude Medical, Inc. (STJ) [hlAlert]

up 68.91 %

St. Jude Medical, Inc. (STJ) rated Buy with price target $48 by UBS

Posted on: Monday,  Feb 6, 2012  12:25 PM ET by UBS

UBS rated Buy St. Jude Medical, Inc. (NYSE: STJ) on 02/06/2012, when the stock price was $42.88. Since
then, St. Jude Medical, Inc. has gained 68.91% as of 01/28/2016's recent price of $72.43.
If you would have followed this UBS's recommendation on STJ, you would have gained 68.91% of your investment in 1452 days.

St. Jude Medical, Inc. (St. Jude)develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiology and cardiac surgery and atrial fibrillation therapy areas and implantable neurostimulation devices for the management of chronic pain. The Company operates in four business segments: Cardiac Rhythm Management (CRM), Cardiovascular (CV), Atrial Fibrillation (AF) and Neuromodulation Systems (Neuro). On July 3, 2008, the Company completed the acquisition of EP MedSystems, Inc. On December 19, 2008, St. Jude acquired Radi Medical Systems. On December 22, 2008, St. Jude acquired MediGuide Inc.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/6/2012 12:25 PM Buy
42.88 48.00
as of 12/31/2012
1 Week down  -0.05 %
1 Month up  5.42 %
3 Months down  -14.21 %
1 YTD up  5.36 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/19/2010 12:25 PM Buy
40.08 46.00
6/9/2009 8:25 AM Hold
1/26/2009 11:25 AM Buy
32.09 36.00
7/17/2008 10:25 AM Hold
47.62 48.00
1/24/2008 9:25 AM Hold
41.65 45.00
9/20/2007 9:25 AM Sell
45.10 43.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy